EULEXIN Side Effects

5132528-3 | Pituitary Tumour, Prolactinoma
on Oct 04, 2006 Male patient from NORWAY , 78 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). Patient experienced the following unwanted or unexpected effects: pituitary tumour, prolactinoma. Eulexin dosage: 250 Mg; Tid;. Patient was hospitalized.

4952185-6 | Aortic Arteriosclerosis, Arteriosclerosis Coronary Artery, Blood Pressure Inadequately Controlled, Circulatory Collapse, Dialysis, Dizziness, Emphysema, Hepatic Fibrosis, Hepatic Necrosis
Patient was taking Eulexin (View Usage). Patient had the following side effects: aortic arteriosclerosis, arteriosclerosis coronary artery, blood pressure inadequately controlled, circulatory collapse, dialysis (What is dialysis?), dizziness (What is dizziness?), emphysema, hepatic fibrosis, hepatic necrosis on Mar 09, 2006 from DENMARK Additional patient health information: Male patient , 74 years of age, weighting 251.3 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Eulexin dosage: 750 Mg Qd Oral. During the same period patient was treated with GOSERELIN (View Goserelin Review and Goserelin Label ), ZOLADEX (View Zoladex Review and Zoladex Label ). Patient was hospitalized.

4846027-7 | Myelodysplastic Syndrome, Oedema Peripheral, Pruritus, Rash Macular, Retinal Vascular Occlusion, Visual Acuity Reduced
Adverse event was reported on Nov 21, 2005 by a Male patient taking Eulexin (View Usage) (Dosage: Oral) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 80 years of age, weighting 189.6 lb, After Eulexin was administered, patient had the following side effects: myelodysplastic syndrome, oedema peripheral, pruritus, rash macular, retinal vascular occlusion, visual acuity reduced. During the same period patient was treated with LUPRON (22.5mg Q3m Intramuscular) (View Lupron Review and Lupron Label ).

4823385-0 | Interstitial Lung Disease, Lung Infiltration, Pulmonary Fibrosis, Restrictive Pulmonary Disease
on Oct 28, 2005 Male patient from FRANCE , 82 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, lung infiltration, pulmonary fibrosis (What is pulmonary fibrosis?), restrictive pulmonary disease. Eulexin dosage: 750 Mg Qd Oral. During the same period patient was treated with DECAPEPTYL (View Decapeptyl Review and Decapeptyl Label ).


4816246-4 | Atrial Fibrillation, Chest Discomfort, Electrocardiogram St Segment Elevation
on Oct 17, 2005 Male patient from SWEDEN , 80 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), chest discomfort, electrocardiogram st segment elevation. Eulexin dosage: 250 Mg Tid Oral. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4801718-9 | Bronchoalveolar Lavage Abnormal, Hypoxia, Lung Disorder, Lung Infiltration
Patient was taking Eulexin (View Usage). After Eulexin was administered, patient had the following side effects: bronchoalveolar lavage abnormal, hypoxia, lung disorder, lung infiltration on Sep 29, 2005 from FRANCE Additional patient health information: Male patient , 82 years of age, . Eulexin dosage: 750 Mg Qd Oral.

4801368-4 | Bronchoalveolar Lavage Abnormal, Hypoxia, Lung Disorder, Lung Infiltration
Adverse event was reported on Sep 29, 2005 by a Male patient taking Eulexin (View Usage) (Dosage: 750 Mg Qd Oral) . Location: FRANCE , 70 years of age, Patient experienced the following unwanted or unexpected effects: bronchoalveolar lavage abnormal, hypoxia, lung disorder, lung infiltration.

4774807-5 | Anaemia, Arthralgia, Disseminated Intravascular Coagulation, Haematoma, Microangiopathy, Pain, Post Procedural Complication, Post Procedural Haemorrhage, Prostatic Specific Antigen Increased
on Sep 08, 2005 Male patient from UNITED STATES , 65 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). Patient had the following side effects: anaemia, arthralgia, disseminated intravascular coagulation, haematoma, microangiopathy, pain (What is pain?), post procedural complication, post procedural haemorrhage, prostatic specific antigen increased. Eulexin dosage: 250 Mg Tid Oral. During the same period patient was treated with LUPRON (7.5 Mg Intramusular) (View Lupron Review and Lupron Label ), NIACIN (View Niacin Review and Niacin Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

4694028-4 | Fall, Hip Fracture, Malignant Neoplasm Progression, Prostate Cancer
on Jun 07, 2005 Male patient from , 97 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). After Eulexin was administered, patient had the following side effects: fall (What is fall?), hip fracture, malignant neoplasm progression, prostate cancer (What is prostate cancer?). Eulexin dosage: 125mg.

4591418-5 | Pneumonia
Patient was taking Eulexin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?) on Feb 11, 2005 from Additional patient health information: Male patient , 89 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eulexin dosage: Oral.

4584831-3 | Acute Respiratory Distress Syndrome, Hip Fracture, Pneumonia, Post Procedural Complication, Respiratory Failure
Adverse event was reported on Feb 04, 2005 by a Male patient taking Eulexin (View Usage) (Dosage: Oral) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: , 82 years of age, Patient had the following side effects: acute respiratory distress syndrome, hip fracture, pneumonia (What is pneumonia?), post procedural complication, respiratory failure. Patient was hospitalized.

4573839-X | Lung Neoplasm Malignant
on Jan 26, 2005 Male patient from , 76 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). After Eulexin was administered, patient had the following side effects: lung neoplasm malignant. Eulexin dosage: Oral.

4570082-5 | Cardiac Failure
on Jan 21, 2005 Male patient from , 91 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eulexin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Eulexin dosage: Oral.

4570076-X | Lung Neoplasm Malignant
Patient was taking Eulexin (View Usage). Patient had the following side effects: lung neoplasm malignant on Jan 21, 2005 from Additional patient health information: Male patient , 87 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eulexin dosage: Oral.

4561251-9 |
Adverse event was reported on Jan 12, 2005 by a Male patient taking Eulexin (View Usage) (Dosage: Oral) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: , 90 years of age, .